Zobrazeno 1 - 10
of 328
pro vyhledávání: '"M Shoyab"'
Autor:
RI Grove, C Mazzucco, N Allegretto, PA Kiener, G Spitalny, SF Radka, M Shoyab, M Antonaccio, GA Warr
Publikováno v:
Journal of Lipid Research, Vol 32, Iss 12, Pp 1889-1897 (1991)
Recent evidence suggests the possibility that macrophages can influence lipoprotein metabolism. Therefore we investigated the ability of cultured macrophages to alter low density lipoprotein (LDL) uptake in a human liver cell line (HepG2). Conditione
Externí odkaz:
https://doaj.org/article/0c3b4b2925af4d1595f9300be38bbe32
Hybridization of avian myeloblastosis virus (AMV) RNA with DNA immobilized on filters or in liquid with a vast DNA excess was used to measure the viral specific DNA sequences in chicken cells. Newly synthesized viral DNA (v-DNA) appears within an hou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ace26135343839877ceaf31f9da0372
https://doi.org/10.1159/000397570
https://doi.org/10.1159/000397570
Publikováno v:
The Journal of Immunology. 150:5596-5603
Tissue inhibitor of metalloproteinases (TIMP-1) is a potent inhibitor of activated matrix metalloproteinases (MMP) such as collagenase, stromelysin, and gelatinase, and thus helps to control extracellular matrix metabolism and deposition by connectiv
Publikováno v:
Europe PubMed Central
Oncostatin-M (OM), a recently described glycoprotein cytokine, is structurally and functionally related to cholinergic differentiation factor/leukemia inhibitory factor (CDF/LIF) and ciliary neurotrophic factor (CNTF). To determine whether OM, like C
Publikováno v:
The Journal of Immunology. 148:1731-1736
Acute inflammation is characterized by increased liver output of acute phase proteins (APP). Several cytokines including IL-6, leukemia inhibitory factor, and IL-11 are capable of stimulating APP synthesis by hepatocytes and hepatoma cells. We have t
Publikováno v:
Molecular and Cellular Endocrinology. 83:1-9
One of the many effects which have been attributed to the peptide endozepine/diazepam binding inhibitor (Ep/DBI) is the stimulation of adrenocortical and testicular Leydig cell mitochondrial steroidogenesis. We have used two cell lines (Y-1 mouse adr
Publikováno v:
Blood. 86(4)
Oncostatin M (OM) is a 28-kD glycoprotein that exhibits a panoply of biologic effects. Based on histologic observations of increased splenic megakaryocytes in nude mice implanted with an OM-secreting cell line, the thrombocytopoietic properties of OM
Autor:
T Taga, Zhao-Yang Lu, K Yasukawa, T Kishimoto, M Shoyab, R Bataille, J J Gu, G D Yancopoulos, Xue-Guang Zhang, K Turner
Publikováno v:
The Journal of Experimental Medicine
Interleukin 6 (IL-6) is a major growth factor for tumor plasma cells involved in human multiple myeloma (MM). In particular, human myeloma cell lines (HMCL), whose growth is completely dependent on addition of exogenous IL-6, can be obtained reproduc
Publikováno v:
The Journal of biological chemistry. 268(25)
We recently reported the molecular cloning of HER4/p180erbB4, a new member of the epidermal growth factor receptor family, as well as its activation by a partially purified ligand (Plowman, G. D., Culouscou, J.-M., Whitney, G. S., Green, J. M., Carlt
Publikováno v:
Cell growthdifferentiation : the molecular biology journal of the American Association for Cancer Research. 4(7)
Oncostatin M (OM), a 28 kilodalton glycoprotein cytokine, is structurally and functionally related to interleukin 6 and leukemia-inhibitory factor. We reported previously that OM strongly up-regulated low density lipoprotein (LDL) receptors in human